Allergy Therapeutics (AGY), a company focused on allergy vaccines, said on Wednesday that the US Food & Drug Administration or FDA has cleared its Investigational New Drug application or IND, for its ...
Peanut oral immunotherapy may help young children who are highly allergic to peanuts become desensitized to their allergy, or ...
The study found that as far as treating a peanut allergy in children, the younger they are, the more likely they are to ...
Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut Paves the way for start of VLP Peanut vaccine candidate’s Phase I PROTECT trial in ...
McLean, VA (Jan. 26, 2022) – Food Allergy Research & Education (FARE) today announced that it has received a $249,663 award through the Eugene Washington PCORI Engagement Award program to address ...
If treated early enough, young children may be able to overcome their peanut allergies, according to researchers.
A peanut allergy treatment often used on children 4 years old and up in the U.S. is safe for toddlers too, a new study has ...
ABC6d
By Sabela Ojea Allergy Therapeutics PLC said that it has received clearance for an investigational new drug application from the U.S. Food & ...
An altercation at a Connecticut smoothie shop involving a father reportedly upset over his child’s allergic reaction was ...
"The younger the kid, the lower the peanut allergy antibody, the better the impact and we are really excited about that ...
A new study performed a peanut treatment on children ages 1 to 3, finding that younger children could receive therapy for the ...